Articles Equine

17 September 2021

EFSA identifies bacteria resistant to the most relevant antibiotics in equine medicine

The European Food Safety Authority (EFSA) has published a report pointing to the most important bacteria resistant to antibiotics in horses in Europe. The evaluation has been carried out following a methodology composed of information collected through an extensive review of the literature and expert opinion.

The Spanish researchers Christian Gortazar Schmidt, professor of the Animal Health Area at the University of Castilla-La Mancha, Miguel Ángel Miranda Chueca, professor at the University of the Balearic Islands, Antonio Velarde, have participated in its preparation, together with different European experts. , head of the Animal Welfare program of the Institute for Agrifood Research and Technology (IRTA) and Julio Álvarez, of the Veterinary Sanitary Surveillance Center (Visavet) of the Complutense University of Madrid.

The report describes the global situation of bacteria resistant to the antibiotics Actinobacillus equuli, Dermatophilus congolensis, Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Pasteurella spp., Pseudomonas aeruginosa, Rhodococcus equi, Staphylococcus aurecoe subspgalaptocus aureus subspgalaptocus. dysgalactiae / equisimilis and Streptococcus equi subsp. equi and subsp. zooepidemicus.

Among these bacteria, EFSA identified E. coli, Staphylococcus aureus, and R. equi with more than 66% certainty as to the most relevant antimicrobial-resistant bacteria in the European Union, given their importance as causative agents of clinical diseases in horses and clinically relevant levels of antimicrobial resistance. The impact on animal health of these "most relevant" bacteria and their eligibility to be included in the list and categorized within the framework of the animal health law were evaluated in separate scientific opinions.

Assessment of animal diseases caused by bacteria resistant to antimicrobials: Horses. EFSA Journal.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

EFSA identifies bacteria resistant to the most relevant antibiotics in equine medicine

Comments

List

Add

Tag

Related Articles

15 May 2024
Updates on H5N1 Beef Safety Studies

Updates on H5N1 Beef Safety Studies

19 August 2022
Europe has suffered the largest seasonal epidemic of bird flu in history

Europe has suffered the largest seasonal epidemic of bird flu in history

10 April 2022
The COVID-19 pandemic has influenced the notable drop in reported zoonoses in Europe

The COVID-19 pandemic has influenced the notable drop in reported zoonoses in Europe

30 January 2022
EFSA identifies the most relevant antimicrobial resistant bacteria in sheep and goats in the EU

EFSA identifies the most relevant antimicrobial resistant bacteria in sheep and goats in the EU

29 September 2025
Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine as Exemplified by the Swine Pathogen Streptococcus suis

Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine as Exemplified by the Swine Pathogen Streptococcus suis

More news

New hope and compassionate care for animal patients in pain

Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education

Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats

Additive manufacturing to veterinary practice: Recovery of bony defects after the osteosarcoma resection in canines

Antimicrobial drug use in poultry

Newsletter

News of interest

Philanthropic Support and Specialized Surgery Saves Dog with Oral Tumor

Feline asthma syndrome: A retrospective study of the clinical presentation in 29 cats

Feline neurological diseases in a veterinary neurology referral hospital population in Japan

Treatment of cats with feline infectious peritonitis

EVENTS